Anti–PD-1 Checkpoint Therapy Can Promote the Function and Survival of Regulatory T Cells
Sarah C. Vick(Fred Hutch Cancer Center), Jonathan S. Serody(University of North Carolina at Chapel Hill)
Cited by 25
Related Papers
Alternative tumour-specific antigens
|Nature reviews. Cancer|2019|350
CAR-macrophage therapy for HER2-overexpressing advanced solid tumors: a phase 1 trial
|Nature Medicine|2025|189